Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
3,4-Methylenedioxymethamphetamine (1 trial)
Stress Disorders, Post-Traumatic (Phase 2)
Stress Disorders, Traumatic (Phase 2)
Trials (1 total)
Trial APIs (1 total)